Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Bipolar drug approved in Europe

  • Comment

The European Commission has approved oral aripiprazole (Abilify) for the treatment of moderate to severe manic episodes in bipolar disorder.

It is also approved for the prevention of a new manic episode in patients who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.

Aripiprazole is the second atypical antipsychotic to be available in UK for both prevention and treatment of manic episodes in the past five years.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.